WASHINGTON, March 6 (Reuters) - The U.S. Federal Trade Commission sued on Thursday to block medical device coatings maker Surmodics' SRDX.O acquisition by private equity firm GTCR, with the regulatory agency alleging the deal was anticompetitive.
The FTC said the deal would create a combined company controlling more than 50% of the market for outsourced hydrophilic coatings.
"These coatings are often used by medical device manufacturers and are applied to lifesaving medical devices such as catheters and guidewires," the regulatory agency said in a statement.
(Reporting by Kanishka Singh and Jasper Ward in Washington)
((Kanishka.Singh@thomsonreuters.com; +12024508248;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.